JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for MANNKIND CORPORATION · pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Connecticut · House · Senate · $10,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare/Medicaid reimbursement

Health Issues

Issues related to Diabetes care

Defense

Issues related to the Tricare Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.